Macroscopic hematuria as an initial sign of primary urethral cancer. Case report
Keywords:
Primary urethral cancer, urothelial carcinoma, prostate, urethra, hematuria, urethral neoplasms, urologic neoplasms.Abstract
Background: Primary urethral cancer is defined as a tumor whose first lesion is located in the urethra; is very uncommon, represents less than 1% of malignant tumors and 5% of malignant tumors of the urinary system. The extension of this process to the prostate gland creates obstructive and irritative urinary symptoms and acute conditions such as macroscopic hematuria.
Objective: To present the case of a patient with Primary urethral carcinoma in its urothelial variety with macroscopic hematuria as clinical presentation.
Case presentation: Clinical case of a 75-year-old male patient, with macroscopic hematuria as a clinical presentation of primary cancer of the urethra in its urothelial variety, diagnosed anatomopathologically during the hematuria study.
Conclusions: The case presented alerts the scientific community that the diagnosis of primary urethral cancer should be considered in patients with macroscopic hematuria in the absence of obstructive or irritative urologic manifestations, although it is a rare sign as clinical presentation of this disease.Downloads
References
1. Chen H, Zou LL, Dong CJ, Li T, Dong ZQ. Advanced primary urethral cancer: a case report. J Med Case Reports [Internet]. 2019 [cited 2022 Dec 18];13(1):1-6. Available from: https://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-019-2253-y
2. Krukowski J, Czajkowski M, Kłącz J, Wawrzaszek O, Gołębiewska M, Matuszewski M. Primary urethral carcinoma – unexpected cause of urethral stricture. Case report and review of the literature. Medical Ultrasonography [Internet]. 2019 [cited 2022 Dec 18];21(4):494-6. Available from: https://www.medultrason.ro/medultrason/index.php/medultrason/article/view/2015/1445
3. Wenzel M, Deuker M, Nocera L, Coll? Ruvolo C, Tian Z, Shariat SF, et al. Comparison between urothelial and non-urothelial urethral cancer. Front Oncol [Internet]. 2020 [cited 2022 Dec 18];10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880052/pdf/fonc-10-629692.pdf
4- Mano R, Vertosick EA, Sarcona J, Sjoberg DD, Benfante NE, Donahue TF, et al. Primary urethral cancer: treatment patterns and associated outcomes. BJU Int [Internet]. 2020 [cited 2022 Dec 18];126(3):359-66. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483343/pdf/nihms-1599094.pdf
5- Gakis G, Bruins HM, Cathomas R, Compérat EM, Cowan NC, van der Heijden AG, et al. European Association of Urology Guidelines on Primary Urethral Carcinoma-2020 Update. Eur Urol Oncol [Internet]. 2020 [cited 2022 Dec 18];3(4):424-32. Available from: https://www.researchgate.net/publication/342505948_European_Association_of_Urology_Guidelines_on_Primary_Urethral_Carcinoma-2020_Update
6- Farrell MR, Xu JT, Vanni AJ. Current perspectives on the diagnosis and management of primary urethral cancer: a systematic review. Res Rep Urol [Internet]. 2021 [cited 2022 Dec 18];13:325-34. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180270/pdf/rru-13-325.pdf
7- Zhang M, Adeniran AJ, Vikram R, Tamboli P, Pettaway C, Bondaruk J, et al. Carcinoma of the urethra. Hum Pathol [Internet]. 2018 [cited 2022 Dec 18];72:35-44. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975388/pdf/nihms900596.pdf
8- Zeng J, Wang S, Zhong L, Huang Z, Zeng Y, Wu S, et al. Unusual Features of Clear Cell Adenocarcinoma of the Female Urethra: A Case Report and Literature Review. J Clin Med Res [Internet]. 2018 [cited 2022 Dec 18];10(8):665-7. Access: 08/09/2021. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031250/pdf/jocmr-10-665.pdf
Downloads
Published
How to Cite
Issue
Section
License
La revista GME tiene Acceso Abierto (Open Access) a su contenido bajo las premisas de que el libre acceso mejora el sistema de comunicación científica, lo cual elimina cualquier barrera que impida el acceso a la información y de que el mismo autor es el máximo beneficiario de este movimiento, al proporcionarle ventajas tanto en su aspecto económico, científico, como en servicios de valor añadido.
Los autores conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra; podrán establecer acuerdos adicionales para la distribución no exclusiva de la versión de la obra publicada en la revista, con el reconocimiento de haber sido publicado primero en esta revista.
Todo el contenido de esta revista se encuentra en Acceso Abierto, distribuido según los términos de la licencia Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) que permite el uso, distribución y reproducción no comerciales y sin restricciones en cualquier medio, siempre que sea debidamente citada la fuente primaria de publicación.